NORELGESTROMIN AND ETHINLY ESTRADIOL
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NORELGESTROMIN AND ETHINLY ESTRADIOL, covering 2021-02-25 to 2022-04-29. Get the full timeline:
Most recent: FDA Approved: NORELGESTROMIN AND ETHINLY ESTRADIOL — Supplemental Application (Amneal Pharmaceuticals NY LLC)